Home/Filings/4/0001209191-20-022225
4//SEC Filing

McGuire Jonathan Will 4

Accession 0001209191-20-022225

CIK 0001716621other

Filed

Mar 31, 8:00 PM ET

Accepted

Apr 1, 5:56 PM ET

Size

7.7 KB

Accession

0001209191-20-022225

Insider Transaction Report

Form 4
Period: 2020-03-30
McGuire Jonathan Will
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-03-30+450,000450,000 total
    Exercise: $1.02Exp: 2030-03-30Common Stock (450,000 underlying)
  • Award

    Common Stock

    2020-03-30+125,000125,000 total
Footnotes (2)
  • [F1]The reported shares were issued as a restricted stock award ("RSA"). The RSA shall vest and become non-forfeitable in equal semi-annual installments over four years following May 20, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) through each vesting date (for the avoidance of doubt, the first vesting date for the RSA will be November 20, 2020, upon which date 1/8 of the shares covered by the RSA may vest).
  • [F2]The option shall vest in equal monthly installments over four years following March 30, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) to the Company through each vesting date, so that the option is fully vested on March 30, 2024.

Issuer

Ra Medical Systems, Inc.

CIK 0001716621

Entity typeother

Related Parties

1
  • filerCIK 0001345539

Filing Metadata

Form type
4
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:56 PM ET
Size
7.7 KB